ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.
Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.
ACT is a leader in toxicology education, offering well-regarded resources:
ACT members are professional scientists, postdocs, and students representing:
Charles River has a global network of scientific experts offering robust safety assessments of drugs, devices, and chemicals. Experience with all molecules types and regulations to mitigate risk for development.Learn more
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.Learn more
Lovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.Learn more
Noble Life Sciences is a preclinical CRO with decades of experience in drug, vaccine, and device development. GLP and non-GLP services, PK/PD, safety, toxicology, and cell-based assays with a strong focus on oncology and infectious diseases.Learn more
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.Learn more